Status: current, Primitive. Date: 30-Sep 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5110523013 | (S)-metoprolol succinate (substance) | en | Fully specified name | Active | Case sensitive | SNOMED CT core |
| 5110524019 | (S)-metoprolol succinate | en | Synonym | Active | Case sensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| (S)-metoprolol succinate | Is a | Beta-1 adrenergic receptor antagonist | true | Inferred relationship | Some | ||
| (S)-metoprolol succinate | Is a | Propanolamine | true | Inferred relationship | Some | ||
| (S)-metoprolol succinate | Has disposition | Beta-1 adrenergic receptor antagonist | true | Inferred relationship | Some | ||
| (S)-metoprolol succinate | Is modification of | Metoprolol | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Has precise active ingredient | True | (S)-metoprolol succinate | Inferred relationship | Some | 2 |
| Levamlodipine (as levamlodipine besilate) 5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Has precise active ingredient | True | (S)-metoprolol succinate | Inferred relationship | Some | 2 |
Reference Sets
Substance foundation reference set
Australian dialect reference set
Description inactivation indicator reference set
FHIR